Qian Zhu

Prof. Dr. Qian Zhu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2026 in Medicine
Verified
Journal Article
Open access
QLQiaoling Liu
Qiaoling Liu
NCNingxin Mm Chen
Ningxin Mm Chen
QZQian Zhu
Qian Zhu
QLQiaoling Liu
Qiaoling Liu
The objective of this study was to identify risk factors for recurrent cervical high-grade squamous intraepithelial lesions (HSIL/CIN2-3) following loop electrosurgical excision procedure (LEEP), with a particular focus on evaluating the protective effect of human papillomavirus (HPV) vaccination, including effective timing of administration, against disease recurrence. This retrospective study analyzed 343 patients with colposcopy-directed biopsy-confirmed cervical HSIL who underwent LEEP, including 127 vaccinated and 216 unvaccinated individuals. Multivariate logistic regression analysis was employed to identify risk factors associated with HSIL recurrence. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cutoff timing of HPV vaccination for preventing post-LEEP HSIL recurrence. Among the 343 patients, the post-LEEP HSIL recurrence rate was 9.0%. Multivariate logistic analysis identified CIN3 (OR = 2.956, 95% CI 1.046–8.352, P = .041), glandular involvement (OR = 3.517, 95% CI 1.165–10.621, P = .026), positive margins (OR = 2.496, 95% CI 1.100–5.667, P = .029), and persistent HPV infection (OR = 6.253, 95% CI 2.043–19.135, P = .001) as independent risk factors for HSIL recurrence. HPV vaccination was associated with a lower risk of HSIL recurrence (OR = 0.249, 95% CI 0.082–0.760, P = .015). ROC analysis indicated that administration of the HPV vaccine within 6 months post-LEEP was the optimal cutoff time for preventing recurrence (AUC = 0.851, P = .017). Vaccination either before LEEP or within this 6-month postoperative period significantly reduced the risk of HSIL recurrence ( P = .034). CIN3, gland involvement, positive margins, and persistent HPV infection increase the risk of cervical HSIL recurrence after LEEP. HPV vaccination, when administered either before or within 6 months after LEEP, is associated with a lower risk of cervical HSIL recurrence.

27 July 2026 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
XHXiaoyan Huang
Xiaoyan Huang
QZQian Zhu
Qian Zhu
Hemoperitoneum, a well-documented manifestation of various gynecological conditions, is herein presented in the first documented case secondary to retained